Switzerland: PolyPeptide CDMO changes CEO and CFO

PolyPeptide Group, a global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, has appointed Juan-José Gonzalez as its new CEO, effective April 12, 2023, and Lalit Ahluwalia as CFO, effective May 1. Gonzalez has a track record in the healthcare sector, most recently as CEO of Ambu, a company focused on single-use endoscopy. Prior to…

You must be a HMI Subscriber to view this content.

Subscribe Now »